266 related articles for article (PubMed ID: 17895506)
1. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
[TBL] [Abstract][Full Text] [Related]
2. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
3. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
4. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry.
Arcelus JI; Monreal M; Caprini JA; Guisado JG; Soto MJ; Núñez MJ; Alvárez JC;
Thromb Haemost; 2008 Mar; 99(3):546-51. PubMed ID: 18327403
[TBL] [Abstract][Full Text] [Related]
7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Shorr AF; Kwong LM; Sarnes M; Happe L; Farrelly E; Mody-Patel N
Thromb Res; 2007; 121(1):17-24. PubMed ID: 17449088
[TBL] [Abstract][Full Text] [Related]
9. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
13. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.
Magee CJ; Barry J; Javed S; Macadam R; Kerrigan D
Surg Obes Relat Dis; 2010; 6(3):322-5. PubMed ID: 20510295
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
Harenberg J; Piazolo L; Misselwitz F
Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
[TBL] [Abstract][Full Text] [Related]
15. The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.
Warwick D; Rosencher N
Clin Appl Thromb Hemost; 2010 Aug; 16(4):394-405. PubMed ID: 20019020
[TBL] [Abstract][Full Text] [Related]
16. [Venous thromboembolism prophylaxis in orthopaedics and traumatology].
Kessler P
Vnitr Lek; 2009 Mar; 55(3):204-10. PubMed ID: 19378847
[TBL] [Abstract][Full Text] [Related]
17. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
18. Thromboprophylaxis with the low-molecular-weight heparin bemiparin sodium in elderly medical patients in usual clinical practice: the ANCIANOS study.
Rodríguez-Mañas L; Gómez-Huelgas R; Veiga-Fernández F; Ruiz GM; González JM;
Clin Drug Investig; 2010; 30(5):337-45. PubMed ID: 20384389
[TBL] [Abstract][Full Text] [Related]
19. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
20. Prevention of deep vein thrombosis in orthopedic surgery.
Eichinger S; Kyrle PA
Eur J Med Res; 2004 Mar; 9(3):112-8. PubMed ID: 15096320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]